Skip to main content
Log in

Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy

  • Original ARticle
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Due to the increasing use of stereotactic radiotherapy (SRT) in treating advanced liver cancer patients, the purpose of this longitudinal study was to explore the changes and factors related to quality of life (QOL) in patients receiving SRT treatment.

Materials and methods

Liver cancer patients receiving SRT in northern Taiwan were recruited. The patients were followed up during the baseline pre-SRT and the first 6 weeks of SRT (T0 to T6) in assessing functional status and symptom severity, while depression, selected laboratory data, and QOL were assessed every 3 weeks (T0, T3, and T6). Generalized estimating equations (GEE) analysis was used to explore the significant factors related to the change in QOL.

Results

Ninety-nine patients with advanced liver cancer completed seven interviews. The results showed that QOL during SRT was moderate and relatively stable. Performance functional status, depression, the level of albumin, and overall symptom severity were significantly associated with changes in QOL. A further analysis of the relationships between individual symptom severity and QOL revealed that fatigue, lack of appetite, pain, and nausea were the symptoms most affecting QOL across the 6 weeks of SRT.

Conclusion

Liver cancer patients had stable and moderate levels of QOL during SRT. Factors related to QOL across the 6 weeks were multi-dimensional. Both overall symptom severity and selected individual symptoms were important to patients' QOL. These factors should all be carefully assessed and clinically treated to enhance liver cancer patients' QOL during SRT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ballinger GA (2004) Using generalized estimating equations for longitudinal data analysis. Organ Res Methods 7:127–149

    Article  Google Scholar 

  2. Ben-Josef E, Lawrence TS (2005) Radiotherapy for unresectable hepatic malignancies. Semin Radiat Oncol 15:273–278

    Article  PubMed  Google Scholar 

  3. Bianchi G, Loguercio C, Sgarbi D, Abbiati R, Brunetti N, De Simone T, Zoli M, Marchesini G (2003) Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis 35:46–54

    Article  PubMed  CAS  Google Scholar 

  4. Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:S5–S16

    Article  PubMed  Google Scholar 

  5. Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135–1141

    Article  PubMed  CAS  Google Scholar 

  6. Dagnelie PC, Pijls-Johannesma MC, Lambin P, Beijer S, De Ruysscher D, Kempen GI (2007) Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol 18:940–944

    Article  PubMed  CAS  Google Scholar 

  7. Department of Health in Taiwan (2007) Causes of death in 2006 In: Health and National Health Insurance Annual Statistics Information Service, from www.doh.gov.tw/statistic

  8. Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W (2007) The influence of xerostomia after radiotherapy on quality of life: Results of a questionnaire in head and neck cancer. Support Care Cancer, (in press)

  9. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG (1996) Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 14:171–175

    PubMed  CAS  Google Scholar 

  10. Gridelli C, Ardizzoni A, Le Chevalier T, Manegold C, Perrone F, Thatcher N, van Zandwijk N, Di Maio M, Martelli O, De Marinis F (2004) Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 15:419–426

    Article  PubMed  CAS  Google Scholar 

  11. Hawkins MA, Dawson LA (2006) Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 106:1653–1663

    Article  PubMed  Google Scholar 

  12. Hawkins MA, Eccles C, Lockwood G, Cummings B, Ringash J, Knox JJ, Sherman M, Greig P, Gallinger S, Dawson LA (2005) Preliminary results of a phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer. J Clin Oncol (Meeting Abstracts) 23:4127

    Google Scholar 

  13. King MT, Dobson AJ, Harnett PR (1996) A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index—cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30). J Clin Epidemiol 49:21–29

    Article  PubMed  CAS  Google Scholar 

  14. Lai YH, Shun SC, Hsiao YL, Chiou JF, Wei LL, Tsai JT, Kao CY (2007) Fatigue experiences in hepatocellular carcinoma patients during six weeks of stereotactic radiotherapy. Oncologist 12:221–230

    Article  PubMed  Google Scholar 

  15. Lips I, Dehnad H, Kruger AB, van Moorselaar J, van der Heide U, Battermann J, van Vulpen M (2007) Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study. Int J Radiat Oncol Biol Phys 69:656–661

    PubMed  Google Scholar 

  16. McCorkle R, Young K (1978) Development of a symptom distress scale. Cancer Nurs 1:373–378

    Article  PubMed  CAS  Google Scholar 

  17. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  PubMed  CAS  Google Scholar 

  18. Peppercorn J, Herndon J 2nd, Kornblith AB, Peters W, Ahles T, Vredenburgh J, Schwartz G, Shpall E, Hurd DD, Holland J, Winer E (2005) Quality of life among patients with stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. Cancer 104:1580–1589

    Article  PubMed  Google Scholar 

  19. Rustoen T (1995) Hope and quality of life, two central issues for cancer patients: a theoretical analysis. Cancer Nurs 18:355–361

    PubMed  CAS  Google Scholar 

  20. Rustoen T, Moum T, Padilla G, Paul S, Miaskowski C (2005) Predictors of quality of life in oncology outpatients with pain from bone metastasis. J Pain Symptom Manage 30:234–242

    Article  PubMed  Google Scholar 

  21. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the Functional Living Index—Cancer: development and validation. J Clin Oncol 2:472–483

    PubMed  CAS  Google Scholar 

  22. Shacham S (1983) A shortened version of the Profile of Mood States. J Pers Assess 47:305–306

    Article  PubMed  CAS  Google Scholar 

  23. Shang E, Weiss C, Post S, Kaehler G (2006) The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer. J Parenter Enteral Nutr 30:222–230

    Article  Google Scholar 

  24. Shioyama Y, Nakamura K, Anai S, Sasaki T, Ooga S, Saku M, Urashima Y, Yoshitake T, Toba T, Terashima H, Honda H (2005) Stereotactic radiotherapy for lung and liver tumors using a body cast system:setup accuracy and preliminary clinical outcome. Radiat Med 23:407–413

    PubMed  Google Scholar 

  25. Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related. Support Care Cancer 6:101–108

    Article  PubMed  CAS  Google Scholar 

  26. Yamashita H, Nakagawa K, Shiraishi K, Tago M, Igaki H, Nakamura N, Sasano N, Siina S, Omata M, Ohtomo K (2007) Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma:retrospective study. J Gastroenterol Hepatol 22:523–527

    Article  PubMed  Google Scholar 

  27. Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130

    Article  PubMed  CAS  Google Scholar 

  28. Zhou ZH, Liu LM, Chen WW, Men ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL (2007) Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma. Br J Radiol 80:194–201

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was partially supported by a grant from the National Science Council in Taiwan. The authors gratefully acknowledge the assistance of the patients who participated in this study. The authors also thank George Plautz for his editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yeur-Hur Lai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shun, SC., Chiou, JF., Lai, YH. et al. Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. Support Care Cancer 16, 1059–1065 (2008). https://doi.org/10.1007/s00520-007-0384-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-007-0384-y

Keywords

Navigation